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Abstract
Background: Adding, omitting or changing outcomes after a systematic review protocol is published can result in bias
because it increases the potential for unacknowledged or post hoc revisions of the planned analyses. The main objective of
this study was to look for discrepancies between primary outcomes listed in protocols and in the subsequent completed
reviews published on the Cochrane Library. A secondary objective was to quantify the risk of bias in a set of meta-analyses
where discrepancies between outcome specifications in protocols and reviews were found.
Methods and Findings: New reviews from three consecutive issues of the Cochrane Library were assessed. For each review,
the primary outcome(s) listed in the review protocol and the review itself were identified and review authors were
contacted to provide reasons for any discrepancies. Over a fifth (64/288, 22%) of protocol/review pairings were found to
contain a discrepancy in at least one outcome measure, of which 48 (75%) were attributable to changes in the primary
outcome measure. Where lead authors could recall a reason for the discrepancy in the primary outcome, there was found to
be potential bias in nearly a third (8/28, 29%) of these reviews, with changes being made after knowledge of the results
from individual trials. Only 4(6%) of the 64 reviews with an outcome discrepancy described the reason for the change in the
review, with no acknowledgment of the change in any of the eight reviews containing potentially biased discrepancies.
Outcomes that were promoted in the review were more likely to be significant than if there was no discrepancy (relative risk
1.66 95% CI (1.10, 2.49), p=0.02).
Conclusion: In a review, making changes after seeing the results for included studies can lead to biased and misleading
interpretation if the importance of the outcome (primary or secondary) is changed on the basis of those results. Our
assessment showed that reasons for discrepancies with the protocol are not reported in the review, demonstrating an
under-recognition of the problem. Complete transparency in the reporting of changes in outcome specification is vital;
systematic reviewers should ensure that any legitimate changes to outcome specification are reported with reason in the
review.
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Introduction
The systematic review process has been developed to minimise
biases and random errors in the evaluation of healthcare
interventions, using precise and explicit methods [1]. Cochrane
systematic reviews are internationally recognised as among the
best sources, if not the best source, of reliable up-to-date
information on health care interventions [2,3].
One of the key components of a well-formulated review
question is the specification of the particular outcomes of interest.
Cochrane reviews should include all important outcomes that are
likely to be meaningful to clinicians, patients and policy makers.
Including all the important outcomes in a review will highlight
gaps in primary research and encourage trialists to address these
gaps in future studies. The Cochrane Handbook provides
guidelines for specifying outcomes [4]. It states that there should
generally be no more than three specified primary outcomes which
should normally include at least one potential benefit and at least
one potential area of harm. Non-primary outcomes should be
listed as a limited number of secondary outcomes. Secondary
outcomes, for example surrogate measures, should be used to help
explain effects and should not be considered as main outcomes as
they are less important than clinical endpoints for informing
decisions.
Preparing a review is a complex process and can often require
many decisions and judgements. Before a review begins, a protocol
should be developed to establish in advance the methods that will
be used. The protocol is an essential component when conducting
a systematic review. It ensures that the review could be replicated
by independent researchers and it reduces the risk of bias through
explicitly stating a priori hypotheses and methods which should be
determined without prior knowledge of results. Clearly, when no
protocol is available, any such bias may go undetected.
In an individual RCT, outcome reporting bias (ORB) has been
defined as the selection for publication of a subset of the original
recorded outcome variables based on the results [5]. It is equally
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systematic review level. The purpose of this study is to identify
inconsistencies between outcomes published in review protocols
and in the associated published reviews, in relation to the potential
bias such changes may introduce. Making changes after seeing the
results for included studies can lead to biased and misleading
results if the importance of the outcome (primary or secondary) is
changed on the basis of those results. Two previous similar studies
have investigated the prevalence of discrepancies between
outcome definitions in published protocols and their associated
reviews [6,7] but our study adds information on the reasons for
discrepancies, enabling an assessment of the potential for bias.
Finally, we discuss the potential seriousness of the biases outlined
in our findings along with recommendations to overcome the
problems encountered.
Methods
As part of a larger project investigating the prevalence and
impact of outcome reporting bias in randomised trials on
systematic reviews [8], discrepancies between specified protocol
and review outcomes were also assessed in 309 new reviews
published on the Cochrane Library between Issue 4, 2006 and
Issue 2, 2007. Twelve reviews from the Cochrane Methodology
Review Group were excluded leaving a total of 297 reviews to be
assessed.
If no protocol had been published on the Cochrane Library,
reviewers and Collaborative Review Groups (CRGs) were asked to
provide a reason for this.
Two investigators (JJK, SD) independently examined the full
protocol to determine whether the protocol specified no, one, or
more than one primary outcome. Any discrepancies between the
assessments were resolved through discussion. A protocol was said
to have specified no primary outcome if outcomes were listed, but
there was no indication which of these listed outcomes were the
primary, the main or most important. The process was then
repeated for the reviews. We then compared the protocol primary
outcome(s) with those reported as primary in the published review,
and any discrepancies (additions, omissions or changes) were
noted. The review text was examined to see if (i) a declaration of
the change from the protocol was made and (ii) an explanation for
this change was given. When no indication of change was provided
in the review, review authors were contacted and asked for the
reason for the change.
Inconsistencies between protocol and review primary outcomes
were classified as follows: (a) inclusion of at least one new primary
outcome in the review that was not specified at all (i.e. as either a
primary or secondary outcome) in the protocol, (b) exclusion of at
least one primary outcome in the review that was listed as a
primary outcome measure in the protocol and (c) change in the
primary outcome(s) specified in the protocol and review. If a change
in primary outcomes had occurred, this was classified as either an
upgrade or downgrade.A nupgrade occurred if a secondary protocol
outcome was promoted to a review primary outcome and a
downgrade occurred if a protocol primary outcome was demoted to
a review secondary outcome. An upgrade also occurred if the review
specified primary outcome(s) but the same outcomes listed in the
protocol were not listed with any order of importance, i.e. primary
or secondary. A downgrade also occurred if the protocol specified
primary outcome(s) but the same outcomes listed in the review had
no order of importance. It is possible that both upgrades and
downgrades could occur in a single review if primary and
secondary outcome measures are swopped over between protocol
and review. Similarly inclusions and exclusions could occur in the
same review. Discrepancies were classified and discussed with the
reviewer until the final overall classification was agreed for each
discrepancy. Our findings were fed back to the relevant CRG and
lead reviewers.
Meta-analysis results were extracted for each primary review
comparison. The primary review comparison was selected for each
review according to the following hierarchy by selecting that which
met the first of the following criteria: (1) an intervention
comparison described in the protocol as the primary review
comparison; (2) the first intervention comparison mentioned in the
objectives of the protocol; (3) an intervention comparison
described in the review as the primary review comparison; (4)
the first intervention comparison mentioned in the objectives of
the review; (5) the intervention comparison used in the first meta-
analysis presented in the review.
The relative risk of obtaining a significant result for inclusions/
upgrades, and then downgrades, compared to meta-analyses with no
discrepancies was estimated. If a protocol outcome was included or
upgraded to a review primary outcome, and the meta-analysis for
that outcome gave a significant pooled effect estimate (p,0.05),
then this would increase our suspicion of bias since the reason for
the inclusion/upgrade could have been influenced by the
significance of the result. If this hypothesis were true then we
would expect the likelihood of a significant meta-analysis result to
be higher for inclusions/upgrades when compared to meta-
analysis results with no discrepancies. Conversely, if an outcome
was downgraded in the review then our suspicion would be raised
that this decision had been influenced by a non-significant
(p.0.05) pooled effect estimate. If this hypothesis were true then
we would expect the risk of a significant result to be lower for




Eight percent (24/297) of reviews did not have a protocol
sourced next to the review under the ‘‘Protocol and previous
versions’’ section on the Cochrane Library. The reason was not
provided by two lead review authors. Seven (2% of 295 reviews)
did not have a protocol: five reviewers went straight from
registered title to review and two reviews were published by an
alternative source and were later updated and developed into a
Cochrane review using Cochrane guidelines. For the remaining 15
reviews, the reviewer authors sent a copy of the protocol. These
protocols were missing from the ‘‘Protocol and previous versions’’
section of the Cochrane Library because a) the review was split
into a number of separate reviews and only one protocol was
registered (9 reviews), b) a draft protocol was accepted by the
Cochrane Review Group (CRG) but was not registered on the
Cochrane Library as it was never formally published (4 reviews)
and c) the reviewer thought the protocol was registered on the
Cochrane Library but its source location could not be found (2
reviews). For this last category, the CRG was contacted and the
protocols had been withdrawn from the Library on the advice of
the Collaboration because they were seen to be out of date. Thus
288 protocol-review pairs were available for study.
Comparison of outcome measures
Figure 1 shows the breakdown of the number of primary
outcomes specified in the protocol and review for the cohort of 288
reviews where protocols existed. The median number of primary
outcomes specified in the protocol and review was the same:
median 1, IQR (0,2). Twenty nine percent (84/288) of protocols
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and 68 of the 84 associated reviews made no distinction either.
Sixty-four (22%) of 288 reviews contained a discrepancy in at least
one outcome measure of which 48 (75%) were attributable
to changes in the specification of at least one primary outcome
measure. The 48 discrepancies in the primary outcome are
identified in Figure 1, however the remaining 16 discrep-
ancies which were not in primary outcomes are not shown in
this figure.
After contacting reviewers with a discrepancy in the protocol/
review primary outcome(s), 34/48 (71%) lead reviewers replied but
only 28 (58%) could recall a reason for the discrepancy (Table 1).
From the reasons provided, it is clear that there is potential for bias
in at least 29% (8/28) of reviews with discrepancies, where
changes were made after knowledge of all results.
Sixty seven percent of the review discrepancies involved either
an inclusion or an upgrade where at least one primary outcome was
added to the review that was not mentioned in the protocol. From
a total of 245 meta-analyses of primary review comparisons from
148 reviews, 85 of these analyses showed a significant result
(p,0.05) in favour of the intervention while 160 analyses showed a
non-significant result (p.0.05). Table 2 provides a comparison of
the significance of the results depending on whether an inclusion,
upgrade or downgrade was found. There was an increased risk of
obtaining a significant result in the meta-analysis if the discrepancy
was either an inclusion or an upgrade than if there was no
discrepancy (relative risk 1.66 95% CI (1.10, 2.49), p=0.02).
When considering protocol primary outcomes that were changed
to secondary outcomes or not listed with any order of importance
in the review (downgrades), there was no discernable decreased risk
of obtaining a significant result in the meta-analysis than if there
was no discrepancy (relatively risk 0.95 95% CI (0.41, 2.19,
p=0.90).
A thorough examination of the review text revealed that only
4(6%) of the 64 reviews with deviations from the protocol
outcome specifications described the reason for the changes in the
review. In all four of these reviews, the reason for the discrepancy
reported in the review matched the reason provided when the
reviewer was contacted. None of these acknowledgments were
from the eight reviews containing potentially biased discrepan-
cies.
Discussion
Our study has shown substantial agreement between Cochrane
reviews and prior protocols over the last few years but also
highlights a concern about a previously unreported source of bias.
Discrepancies between the specification of outcome measures in
protocols and reviews have been described previously but, to our
knowledge, this is the first study that has sought the reasons for
such discrepancies. Bias was suspected in 29% (8/28) of reviews
with discrepancies in specified primary outcomes, where changes
were made after knowledge of all results. None of these reviews
reported the reason for the discrepancy, demonstrating an under-
recognition of the problem.
This study provides evidence that outcome reporting bias, as a
result of changing the defined importance of an outcome, occurs in
the systematic review process as well as for individual randomised
controlled trials [9]. A systematic review of the empirical evidence
of outcome reporting bias in trial primary outcomes found that
40–62% of studies have at least one primary outcome that was
changed, introduced, or omitted and that outcomes that are
statistically significant have higher odds of being fully reported
(range of odds ratios: 2.2 to 4.7) [10]. Our study shows that ORB
does not appear to be limited to individual trials but also occurs in
systematic reviews.
Figure 1. A flow diagram showing the discrepancies between protocol and review primary outcomes. The shaded areas indicate where
the discrepancies were found.
doi:10.1371/journal.pone.0009810.g001
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Higgins et al. [11] reported 28% (11/39) reviews with
unpublished protocols in Issue 2 1999, while Silagy et al. [6]
reported 29% (16/66) protocols missing from the Cochrane
Library from Issue 3, 2000. A later study reported 12% (14/120)
missing protocols from reviews published in 2005/06 (Parmelli et
al. [7]). However, none of these studies mentioned whether review
authors were contacted to enquire if a protocol was available on
request. Our study found 8% (24/297) of reviews did not have a
protocol on the Cochrane Library, but after obtaining unpublished
protocols from review authors, we found that only 2% of reviews
in the study cohort had no protocol. Systematic reviews that are
not Cochrane reviews are less likely to have a protocol and so any
post hoc changes cannot be identified if not indicated in the review.
Only 11% of non-Cochrane therapeutic reviews in 2004
mentioned a protocol [3].
In this current study we found that 25% (75/297) of reviews did
not distinguish between primary and secondary outcomes, an
improvement over a study that reported a rate of 47% for reviews
between 1998 and 2005 [12].
Discrepancies between any outcomes specified in the protocol
and the review was found in nearly a quarter (22%) of the reviews
we examined. The majority of these (75%) were attributable to
changes in the specification of primary outcome measures. These
results show improvement over an 81% discrepancy rate reported
for Cochrane reviews published in 2000 [6] and 47% for reviews
published in 2005/06. [7].
Non-significant meta-analysis results were found when out-
comes were downgraded while upgrades or inclusions favoured
statistically significant outcomes when compared to the results
where no discrepancy in outcome definition was found. In
addition, two reviews downgraded or excluded the protocol primary
Table 1. Reasons for discrepancies in primary outcome measures.
Change
Reasons for discrepancy between
primary outcome(s) specified in the







Recommendation by editors/peer reviewers - 1 1 3 2 - 7
Recognition of the importance of the outcome
before reading the results for the included trials
--- 5 2 - 7
{Recognition of the importance of the outcome
after reading the results for the included trials
3- - 2 2 - 7
{Outcome reflects the same domain as another
outcome specified. Decision made after reading
the results for the included trials
-1 - - - - 1
No results reported in the literature - 1 - - 1 - 2
Change in author from protocol/review – change
reflects opinion of the importance of the
outcome from another expert
11- 2 - -
*4
Reviewer responded but could not recall
reason for discrepancy
--- 6 - - 6
No response from authors 2 1 1 5 4 1 14
Total 6 5 2 23 11 1 48
{Reasons where potential bias was suspected.
*Delay between publication of the review and protocol for these four reviews: 27 months, 66 months, 75 months and 99 months (median for all 288 reviews was2 4
months).
doi:10.1371/journal.pone.0009810.t001
Table 2. A comparison of the significance of meta-analysis results for primary review comparisons between outcomes that are
either inclusions, upgrades or downgrades in the review and those outcomes where there are no discrepancies between protocol
and review.





Type of discrepancy Inclusions 3 (3) 2 (2) 5 (5)
Upgrades 11 (7) 10 (10) 21 (17)
Downgrades 4 (3) 9 (6) 13 (9)
No discrepancy 67 (46) 139 (71) 206 (117)
85 (59) 160 (89) 245 (148)
Numbers in parentheses represent the number of reviews affected by each discrepancy.
doi:10.1371/journal.pone.0009810.t002
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reported in the literature.
Conclusions and policy implications for systematic
reviews
Our study shows substantial improvements in Cochrane reviews
over time with respect to outcomes. There is still room to increase
the quality however, and we would recommend the following. The
reviewer, and especially the CRG, should ensure that the policy of
writing and registering a carefully designed protocol prior to the
start of each review is followed. The Cochrane Handbook
recommends that up to a maximum of seven desirable and
undesirable outcomes (listed in order of importance) that are
essential for decision-making should be decided by reviewers
during protocol development and included in the ‘Summary of
findings’ section of the review. CRGs should be encouraged not to
allow reviewers to proceed with the review before a protocol has
been reviewed by an appropriate external review panel. When one
protocol is written for multiple reviews, it should be made clear
where the protocol is located on the library. Most importantly,
systematic review protocols should be made publicly available to
deter, and enable the identification of, outcome reporting bias and
unacknowledged post hoc amendments to pre-specified outcomes.
The Cochrane Handbook acknowledges that review authors
should be alert to the possibility that the importance of an outcome
may only become known after the protocol was written or the
analysis was carried out, and should take appropriate actions to
include these in the review. There is still a need for reviewers to
describe the legitimacy of adding or changing outcomes after the
protocol was published in order to prevent any suspicion of bias as
well as adhering to these current Cochrane guidelines. Moreover,
outcome definitions should not be changed because they are more
frequently addressed in the studies that are being reviewed, nor
changed on the basis of observed magnitude of effect.
As well as being aware of potential outcome reporting bias in
the systematic review process, it is important for reviewers to assess
the impact of this type of bias in the clinical trials within the
review. A systematic empirical study of the impact of outcome
reporting bias in randomised controlled trials on the results of
systematic reviews revealed that a third of Cochrane reviews (96/
283, 34%) contained at least one trial with high ORB suspicion for
the review primary outcome [8]. Moreover, ORB was suspected in
a single primary review outcome in 14% (359/2486) of assessable
randomised controlled trials [8]. The adoption of the new
Cochrane risk of bias tool, which includes a judgment of the risk
of selective outcome reporting for included studies, should also
help to raise awareness of outcome reporting bias.
By looking at only Cochrane systematic reviews, we suspect that
our study underestimates bias due to changes in outcome
specification during the systematic process. Cochrane reviews
are not only monitored by a CRG but also the Cochrane
Handbook provides guidelines which offer some protection against
this type of bias [4]. A recent commentary calls for the registration
of all systematic reviews [13]. Such a registry may reduce
publication bias in reviews as well as enhancing transparency
and avoiding duplication of effort. In addition, the recently
published PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) statement has evolved to help ensure
the clarity and transparency of reporting of systematic reviews
[14]. The statement specifically asks review authors to report on
registration and availability of their systematic review protocol in
order to reduce the risk of flawed reporting of systematic reviews
that may lead to bias.
The review authors are working with reviewers/CRGs to
improve the reporting of outcome data and to reduce bias in
systematic reviews as an ongoing investigation. Any problems or
suspicions of potential sources of outcome reporting bias are being
fed back to reviewers CRG and thus far the feedback has been well
received.
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